日本HPV疫苗接种可及性:提升社会信任以重建疫苗信心
日本HPV疫苗接种率从2013年约70%骤降至不足1%并持续7年,构成疫苗犹豫危机。该文以架构、可及性、可负担性和采纳四个维度分析障碍,发现决策机构架构、公共信息可得性、政策制定中证据采纳、提供者知识与信心、公众教育及与终端用户沟通均存在显著问题。作者据此提出政府、市政、专业协会、政治家、民间社会和大众媒体等多方行动建议,以建立利益相关者互信,重建HPV疫苗信心。
要点
- 日本HPV疫苗接种率2013年从约70%降至不足1%并持续7年。
- 障碍涉及决策架构、信息可得性、证据采纳、提供者信心与公众沟通。
- 建议政府、专业协会、媒体等多方协作以重建社会信任和疫苗信心。
核心结论
- 日本HPV疫苗危机源于社会信任丧失,需通过多方行动建立互信以重建疫苗信心并减少可预防的死亡和并发症。
研究设计与样本
- 本文为针对日本HPV疫苗犹豫案例的分析性文章,采用架构、可及性、可负担性和采纳四类框架审视卫生技术可及性与使用障碍。
主要发现
- 日本HPV疫苗接种率从2013年约70%快速下降至不足1%,并持续7年。
- 在决策机构架构、公共信息可得性、政策制定中证据采纳、提供者知识与信心、公众教育及与终端用户沟通方面发现显著问题。
临床怎么用
- 国家政府应使咨询委员会多元化,纳入更广泛科学证据和多种观点。
- 市政当局应与当地提供者合作积极分发信息。
- 专业协会应建立联盟以影响政策制定者并向卫生保健提供者和终端用户提供教育。
- 政治家应整合公民和科学家意见以实施最新政策。
- 民间社会应分享宫颈癌患者个人故事和接种女孩的正面经历,大众媒体应使用更多元信息来源进行科学报道。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vaccine hesitancy is a growing concern in global public health, and illustrates serious problems arising from loss of social trust. Japan is experiencing a human papillomavirus (HPV) vaccine crisis that started with a rapid decline in the vaccination rate in 2013 from approximately 70% to less than 1% and lasting for 7 years. We analyze Japan's case of vaccine hesitancy for HPV vaccine, using a framework for examining barriers to access and use of health technologies according to four categories: architecture, availability, affordability, and adoption. Significant problems were identified in the architecture of the decision-making body, public information availability, adoption of evidence in policy-making process, knowledge and confidence among providers, education to the public, and communication with end-users. We propose a series of actions to address these barriers. The national government should diversify the advisory committee to include broader scientific evidence and various viewpoints. Municipalities should actively distribute information cooperating with local providers. Professional associations should create an alliance to influence policy makers and deliver education to health care providers and end-users. Politicians should integrate opinions from citizens and scientists to implement an up-to-date policy. Civil society should share individual stories from cervical cancer patients and positive experiences of vaccinated girls. Mass media should use more diverse sources of information to report more comprehensive and science-based views. These actions would help build mutual trust among stakeholders, which is required to increase social trust in the HPV vaccine in Japan and thereby regain vaccine confidence and reduce preventable deaths and complications.
引用
- Kunitoki K, Funato M, Mitsunami M, et al. Access to HPV vaccination in Japan: Increasing social trust to regain vaccine confidence. Vaccine. 2021. PMID: 34507858. doi:10.1016/j.vaccine.2021.08.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。